RO7126209
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RO7126209, covering 2021-08-09 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]